Who
Jonathan Allan
General Counsel & Corp Sec
Company insider
Files Form 4 as: General Counsel & Corp Sec, Stoke Therapeutics.
In numbers
- Trades disclosed
- 103
- Buys
- 0
- Sells
- 25
- Bought
- $0
- Sold
- $3.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Mar 2023
- Last trade
- 2 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Oct 2026filed 2 Oct 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $17K627 at $26.33 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $87K2,716 at $32.01 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,708145 at $32.47 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $87K2,716 at $32.01 | filing |
| 18 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,708145 at $32.47 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Code M | —6,000 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $44K1,457 at $29.95 | filing |
| 16 Jun 2026filed 18 Jun 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $44K1,457 at $29.95 | filing |
| 20 Mar 2026filed 24 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $292K8,692 at $33.64 | filing |
| 20 Mar 2026filed 24 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K601 at $34.41 | filing |
| 20 Mar 2026filed 24 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $292K8,692 at $33.64 | filing |
| 20 Mar 2026filed 24 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $21K601 at $34.41 | filing |
| 18 Mar 2026filed 19 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $132K4,222 at $31.28 | filing |
| 18 Mar 2026filed 19 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K334 at $31.79 | filing |
| 18 Mar 2026filed 19 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,36572 at $32.85 | filing |
| 18 Mar 2026filed 19 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $132K4,222 at $31.28 | filing |
| 18 Mar 2026filed 19 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K334 at $31.79 | filing |
News
No headline names them, or the companies they trade most, lately.